Acibadem Sistina

Publikime

•          07.08.2025- Hristov, D., & Stojanov, D. (2025). The State-of-the-Art Review on FSHR, LHCGR, AR, ESR1, and ESR2 Key Mutations and Their Impact on the Effectiveness of Infertility Therapies—What We Know So Far. Receptors4(3), 16.

•          21.05.2025- Elsevier: Hristov D, Stojanov D,In silico report on five high-risk protein C pathogenic variants: G403R, P405S, S421N, C238S, and I243T,Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis,Volume 831,2025,111907,ISSN 0027-5107,

https://doi.org/10.1016/j.mrfmmm.2025.111907.

•          26.06.2024 -  MDPI : Hristov, D.; Stojanov, D. Exploring Regulatory Properties of Genes Associated with Nonsyndromic Male Infertility. Reprod. Med. 20245, 136-153. https://doi.org/10.3390/reprodmed5030013

 
Коавтор:
 

•          2021 - S Stojkovska, G Dimitrov, Z Petanovski, D Shushleski, S Saltirovski, V Matevski, M Hadzi Lega, V Sotirovska, D Stojanovska, N Stamenkovska, E Petanovska Kostova, R Latifi Isaki. A novel method of treating ovarian infertility: Is platelet-rich plasma a new promising therapy in the future? MMP 2021.

•          2020 - Kostova EP, Sotirovska V, Stojanovska D, Prodanova I, Petanovski Z. Immature Ovarian Teratoma. Donald School J Ultrasound Obstet Gynecol 2020; 14 (4):359-363.

•           2020 - E Petanovska Kostova, V Sotiroska, G Dimitrov, S Stojkovska, M Hadzi Lega, D Stojanovska, N Stamenkovska, L Simjanovska, Z Petanovski. Different Timing of Adjuvant Low Dose hCG and GnRH Agonist Trigger Protocol, in OHSS High-Risk Patient with Peak E2 Level. Gynecol Obstet Reprod Med. 2020;26(0):000-000.

    

Copyright © 2025 Developed by Unet All rights reserved.